On the contrary, tissue-resident NK cells are mainly enriched in a subset of NK cells, known as CD56 bright, which are capable of releasing pro-inflammatory cytokines and chemokines that could promote direct anti-tumor activity, beyond innate and adaptive responses [3,4]. This evidence concerns the gene NCAM1 and neoplasm.